GPT-Rosalind (OpenAI) vs Augment Code Intent

Augment Code Intent is the clear winner: 8.0/10 (A-tier) versus 6.8/10 (C-tier). GPT-Rosalind (OpenAI) isn't a bad tool, but on every category that drives the overall score, Augment Code Intent comes out ahead. The tier gap is repeatable -- not methodology noise -- and the day-to-day experience reflects it.

Neither tool offers a free tier. GPT-Rosalind (OpenAI) starts at Invite only, Augment Code Intent at Included in Auggie subscription. Plan to budget for whichever you pick. The cheap tier usually caps out faster than buyers expect, so look at what the entry plan actually includes -- both vendors have raised list prices in 2026 and the limits are where most of the cost surprise lives.

By use case: pick GPT-Rosalind (OpenAI) when researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get trusted access. Pick Augment Code Intent when engineering teams already using augment code's auggie or running mixed claude-code + codex workflows who want higher-level orchestration than writing langgraph graphs from scratch. The two tools aren't fighting for the same person -- they're aiming at adjacent jobs that occasionally overlap. If you're squarely in Augment Code Intent's lane, the tier-list ranking and the use-case fit point the same direction; if you're in GPT-Rosalind (OpenAI)'s lane, the score gap matters less than the fit.

Bottom line: Augment Code Intent is the better tool for most people right now. Pick GPT-Rosalind (OpenAI) only when researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get trusted access -- that's its lane, and inside that lane it still earns its place.